(Q77933836)

English

Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention

scientific article published on 01 July 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sanjeev Kumar Sharma

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

G Dangas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J D Marmur

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T E King

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J De Leon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

R Vidhun

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D Feldman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Y Stoynov

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J J Badimon

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J A Ambrose

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

138

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

49-54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Identification of active tissue factor in human coronary atheroma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Management of restenosis after coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Unstable angina. A classification

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Correlation of angiographic morphology and clinical presentation in unstable angina.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complicatio

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Identifiers

10.1016/S0002-8703(99)70245-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77933836&oldid=1753718597"